Cargando…

Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer

BACKGROUND: Mammalian forkhead members of the class O (FOXO) transcription factors, including FOXO1, FOXO3a, and FOXO4, are implicated in the regulation of several biological processes, including the stress resistance, metabolism, cell cycle, apoptosis and DNA repair. The objectives of this study we...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Sanjit K, Srivastava, Rakesh K, Shankar, Sharmila
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915986/
https://www.ncbi.nlm.nih.gov/pubmed/20642839
http://dx.doi.org/10.1186/1750-2187-5-10
_version_ 1782184984223678464
author Roy, Sanjit K
Srivastava, Rakesh K
Shankar, Sharmila
author_facet Roy, Sanjit K
Srivastava, Rakesh K
Shankar, Sharmila
author_sort Roy, Sanjit K
collection PubMed
description BACKGROUND: Mammalian forkhead members of the class O (FOXO) transcription factors, including FOXO1, FOXO3a, and FOXO4, are implicated in the regulation of several biological processes, including the stress resistance, metabolism, cell cycle, apoptosis and DNA repair. The objectives of this study were to examine the molecular mechanisms by which FOXO transcription factors induced cell cycle arrest and apoptosis and enhanced anti-proliferative effects of sulforaphane (SFN, an active compound in cruciferous vegetables) in pancreatic cancer cells. RESULTS: Our data demonstrated that SFN inhibited cell proliferation and colony formation, and induced apoptosis through caspase-3 activation in pancreatic cancer cells. The inhibition of PI3K/AKT and MEK/ERK pathways activated FOXO transcription factors. SFN inhibited phosphorylation of AKT and ERK, and activated FOXO transcription factors, leading to cell cycle arrest and apoptosis. Phosphorylation deficient mutants of FOXO proteins enhanced FOXO transcriptional activity, and further enhanced SFN-induced FOXO activity and apoptosis. SFN induced the expression of p21(/CIP1 )and p27(/KIP1), and inhibited the expression of cyclin D1. CONCLUSION: These data suggest that inhibition of PI3K/AKT and ERK pathways acts together to activate FOXO transcription factor and enhances SFN-induced FOXO transcriptional activity, leading to cell cycle arrest and apoptosis.
format Text
id pubmed-2915986
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29159862010-08-05 Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer Roy, Sanjit K Srivastava, Rakesh K Shankar, Sharmila J Mol Signal Research Article BACKGROUND: Mammalian forkhead members of the class O (FOXO) transcription factors, including FOXO1, FOXO3a, and FOXO4, are implicated in the regulation of several biological processes, including the stress resistance, metabolism, cell cycle, apoptosis and DNA repair. The objectives of this study were to examine the molecular mechanisms by which FOXO transcription factors induced cell cycle arrest and apoptosis and enhanced anti-proliferative effects of sulforaphane (SFN, an active compound in cruciferous vegetables) in pancreatic cancer cells. RESULTS: Our data demonstrated that SFN inhibited cell proliferation and colony formation, and induced apoptosis through caspase-3 activation in pancreatic cancer cells. The inhibition of PI3K/AKT and MEK/ERK pathways activated FOXO transcription factors. SFN inhibited phosphorylation of AKT and ERK, and activated FOXO transcription factors, leading to cell cycle arrest and apoptosis. Phosphorylation deficient mutants of FOXO proteins enhanced FOXO transcriptional activity, and further enhanced SFN-induced FOXO activity and apoptosis. SFN induced the expression of p21(/CIP1 )and p27(/KIP1), and inhibited the expression of cyclin D1. CONCLUSION: These data suggest that inhibition of PI3K/AKT and ERK pathways acts together to activate FOXO transcription factor and enhances SFN-induced FOXO transcriptional activity, leading to cell cycle arrest and apoptosis. BioMed Central 2010-07-19 /pmc/articles/PMC2915986/ /pubmed/20642839 http://dx.doi.org/10.1186/1750-2187-5-10 Text en Copyright ©2010 Roy et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Roy, Sanjit K
Srivastava, Rakesh K
Shankar, Sharmila
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
title Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
title_full Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
title_fullStr Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
title_full_unstemmed Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
title_short Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
title_sort inhibition of pi3k/akt and mapk/erk pathways causes activation of foxo transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915986/
https://www.ncbi.nlm.nih.gov/pubmed/20642839
http://dx.doi.org/10.1186/1750-2187-5-10
work_keys_str_mv AT roysanjitk inhibitionofpi3kaktandmapkerkpathwayscausesactivationoffoxotranscriptionfactorleadingtocellcyclearrestandapoptosisinpancreaticcancer
AT srivastavarakeshk inhibitionofpi3kaktandmapkerkpathwayscausesactivationoffoxotranscriptionfactorleadingtocellcyclearrestandapoptosisinpancreaticcancer
AT shankarsharmila inhibitionofpi3kaktandmapkerkpathwayscausesactivationoffoxotranscriptionfactorleadingtocellcyclearrestandapoptosisinpancreaticcancer